论文部分内容阅读
目的:探讨给予妊娠高血压患者联合应用硝苯地平控释片、酚妥拉明和硫酸镁治疗的临床效果。方法:选取我院于2012年3月~2013年2月收治40例妊娠期高血压患者,随机将患者分为两组,对照组与观察组,两组均为20例;给予对照组患者硫酸镁治疗;观察组患者在硫酸镁的基础上再结合酚妥拉明、硝苯地平控释片进行治疗,对比两组患者在治疗前后的血压与新生儿结局变化。结果:治疗组的收缩压、舒张压的控制效果明显优于对照组,差异有统计学意义(P<0.05);而且治疗组的产妇顺产率、新生儿结局方面均优于对照组,差异有统计学意义(P<0.05)。结论:给予妊娠高血压患者三联药物治疗,疗效显著,值得推广。
Objective: To investigate the clinical effect of combined nifedipine controlled release tablets, phentolamine and magnesium sulfate in patients with pregnancy induced hypertension. Methods: 40 cases of hypertensive patients with gestational hypertension were treated in our hospital from March 2012 to February 2013. The patients were randomly divided into two groups: the control group and the observation group, with 20 cases in both groups. The patients in the control group were treated with sulfuric acid The patients in the observation group were treated with phentolamine and nifedipine controlled release tablets on the basis of magnesium sulfate. The changes of blood pressure and newborns before and after treatment were compared between the two groups. Results: The control effect of systolic blood pressure and diastolic blood pressure of the treatment group was significantly better than that of the control group (P <0.05), and the rate of maternal delivery and neonatal outcome in the treatment group was better than that of the control group Statistical significance (P <0.05). Conclusion: The treatment of hypertensive patients with triple drug therapy, the effect is significant, it is worth promoting.